Home/Filings/4/0001562180-23-005218
4//SEC Filing

Wei Lin 4

Accession 0001562180-23-005218

CIK 0001860782other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:00 PM ET

Size

15.4 KB

Accession

0001562180-23-005218

Insider Transaction Report

Form 4
Period: 2023-06-13
Wei Lin
Director
Transactions
  • Award

    Common Stock

    2023-06-13+4,20020,800 total
  • Award

    Stock Option (right to buy)

    2023-06-13+8,4508,450 total
    Exercise: $11.81Exp: 2033-06-13Common Stock (8,450 underlying)
Footnotes (2)
  • [F1]These restricted stock units vest 100% on the earlier of June 13, 2024 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.
  • [F2]This option vests 100% on the earlier of June 13, 2024 or the date of the next annual meeting of stockholders of 2seventy bio, Inc.

Issuer

2seventy bio, Inc.

CIK 0001860782

Entity typeother

Related Parties

1
  • filerCIK 0001872772

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:00 PM ET
Size
15.4 KB